Skip to content

Novo Integrated Sciences, Inc.: 10-K filed 2013-04-15

What Novo Integrated Sciences, Inc. reported in its annual report filed 2013-04-15 (fiscal FY 2012): 19 published measures, 68 facts as tagged in accession 0001188112-13-001084.

This filing

Form
10-K (annual report)
Filed
2013-04-15
Fiscal period
fiscal FY 2012
Accession
0001188112-13-001084 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Novo Integrated Sciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3134,536USD
At 2011-12-3125,812USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-31-797,356USD
At 2011-12-31-2,328,111USD
At 2010-12-31-1,492,089USD
At 2009-12-31-885,715USD
At 2008-12-31-1,438,841USD
At 2007-12-31-992,448USD
At 2006-12-31-460,336USD
At 2005-12-31-463,433USD
At 2004-12-31-305,082USD
At 2003-12-31-217,977USD
At 2002-12-31-184,786USD
At 2001-12-3116,982USD
At 2000-12-315,971USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-316,293USD
At 2011-12-3111,638USD
At 2010-12-31128,264USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-1,160,250USD366
2000-11-27 to 2012-12-31-17,531,408USD4418
2011-01-01 to 2011-12-31-2,238,011USD365
2010-01-01 to 2010-12-31-2,569,223USD365
2009-01-01 to 2009-12-31-2,271,917USD365
2008-01-01 to 2008-12-31-982,677USD366
2007-01-01 to 2007-12-31-2,470,352USD365
2006-01-01 to 2006-12-31-1,465,077USD365
2005-01-01 to 2005-12-31-1,068,738USD365
2004-01-01 to 2004-12-31-282,009USD366
2003-01-01 to 2003-12-31-190,567USD365
2002-01-01 to 2002-12-31-2,796,768USD365
2001-01-01 to 2001-12-31-31,789USD365
2000-11-28 to 2000-12-31-4,029USD34

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-0.02USD/shares366
2000-11-27 to 2012-12-31-0.72USD/shares4418
2011-01-01 to 2011-12-31-0.04USD/shares365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-3117,538USD
At 2011-12-317,056USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-3116,998USD
At 2011-12-3118,756USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-12-31165,826USD366
2000-11-27 to 2012-12-31784,143USD4418
2011-01-01 to 2011-12-3115,540USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-31241,561USD
At 2011-12-31141,089USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-31118,098USD
At 2011-12-31116,290USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2000-11-27 to 2012-12-313,882,494USD4418
2011-01-01 to 2011-12-31146,779USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3169,169,111shares
At 2011-12-3156,503,946shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-3116,913,769USD
At 2011-12-3114,277,622USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-3169,919USD
At 2011-12-3154,919USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-3152,381USD
At 2011-12-3147,863USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,518USD366
2000-11-27 to 2012-12-3155,464USD4418
2011-01-01 to 2011-12-313,838USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-341,718USD366
2000-11-27 to 2012-12-31-958,291USD4418
2011-01-01 to 2011-12-31-13,796USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-12-31373,350USD366
2000-11-27 to 2012-12-314,251,143USD4418
2011-01-01 to 2011-12-31241,320USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,808USD366
2000-11-27 to 2012-12-31326,936USD4418
2011-01-01 to 2011-12-3172,722USD365

Inspect the source

Entity
Novo Integrated Sciences, Inc. / CIK 0001138978
Captured
2026-09-21T17:18:44.141Z
SEC response SHA-256
2c05b67386a7c51ae2db3b1f04bcf71f64bf887526ff32a3b714db1dcc2aff05

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001138978.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))